Medications for Advanced Melanoma
June 16, 2015|Dermatology
Author and Disclosure Information
As part of our commitment to resident education, Cutis is excited to offer this monthly section with board-relevant, easy-to-review material.
This fact sheet provides a list of the current US Food and Drug Administration approved medications for treatment of metastatic melanoma, and describes their mechanism of action and any related cutaneous side effects.
4. Which of the following medications is a monoclonal antibody to cytotoxic T-lymphocyte–associated antigen 4?
a. aldesleukin
b. dacarbazine
c. ipilimumab
d. recombinant interferon alfa-2b
e. trametinib
